Forma Therapeutics Holdings Long Term Debt

As of the most recent data (June 2022), FMTX shows a long-term debt of $27M. That compares with $2.9M in the prior-year period — up 846.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FMTX's long-term debt is now $27M (was $2.9M) — a 846.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Forma Therapeutics Holdings is outperforming or lagging.

Tracking FMTX's long-term debt over time shows whether Forma Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $27M That compares with $2.9M in the prior-year period — up 846.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Forma Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $27M) with ownership activity and broader fundamentals.

Forma Therapeutics Holdings's long-term debt is $27M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.